Zapping nerves with radiation may ease pancreatic cancer pain

NCT ID NCT07689955

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests whether a short course of precisely targeted radiotherapy can safely reduce severe pain in people with advanced pancreatic cancer. The radiation is aimed at the coeliac plexus, a network of nerves in the abdomen that often causes pain when affected by the tumor. Participants receive Intensity Modulated Radiotherapy (IMRT), a technique that shapes radiation beams to spare healthy tissue. The main goal is to see if pain scores drop by at least 30% without increasing painkiller use. If successful, this approach could offer a non-invasive, widely available pain relief option across the UK.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Intensity Modulated Radiotherapy (IMRT) to the coeliac plexus
What this could lead to
If it works, this could offer a non-invasive, widely available option to ease severe pain in advanced pancreatic cancer, reducing reliance on strong painkillers.
What could go wrong
This is a small, early-phase trial with no control group, so results may not be definitive. Radiotherapy to the abdomen can cause side effects like nausea or fatigue, and pain relief may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.